Diagnostic performance of β-(1→3)-D-glucan, two Candida antigen, and five anti-Candida antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial.
Standl L, Huber T, Bloos F, Thomas-Rüddel D, Träger J, Kluge S, Fichtner F, Simon P, Kogelmann K, de Heer G, Kuhn S, Jarczak D, Motsch J, Hempel G, Weiler N, Weyland A, Drüner M, Gründling M, Meybohm P, Richter D, Moerer O, Günther U, Schädler D, Zarbock A, Putensen C, Castellanos I, Kurzai O, Schlattmann P, Cornely OA, Bauer M, Lehmann T, Valenza G, Bogdan C, Held J; SepNet Critical Care Trials Group.
Standl L, et al.
J Clin Microbiol. 2026 May 13;64(5):e0150025. doi: 10.1128/jcm.01500-25. Epub 2026 Apr 23.
J Clin Microbiol. 2026.
PMID: 42023876
Free PMC article.
Clinical Trial.